|
 |
Nutropin DepotThis page contains recent news articles, when available, and an overview of Nutropin Depot but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....manufactured was $16.8 million in fiscal 2005, consisting of approximately $14.5 million for Risperdal Consta and $2.3 million for Nutropin Depot(R). ... $4.95 - Business Wire - ECNext Press Release: QualityStocks News - Nuvelo, Inc. (NUVO) Trades Higher... - Dec 12, 2008 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C)1994-98 M2 ... completion ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Orexigen Announces Initiation of Phase III Clinical... - May 22, 2007 M2 Presswire; October 23, 1998 ; 700+ words ... ... preliminary results of Phase III clinical trial of Nutropin Depot (C ... completion of a multi-center ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: New Report Contains In-depth Analysis of Phase II and... - Feb 1, 2008 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C)1994 ... completion of a ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Daily Market Movers Digest Stock Alerts, Thursday,... - Jun 15, 2006 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot (C ... completion of a ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Telcyta was Predicted to Reach the Market by Mid-2007 ... - Apr 18, 2007 M2 Presswire; October 23, 1998 ; 700+ words ... ... positive preliminary results of Phase III clinical trial of Nutropin Depot . ... Pay-Per-View - M2 Presswire - HighBeam Research Alkermes Reports First Quarter Fiscal 2006 Financial Results;... - Aug 4, 2005 ...the same period last fiscal year was primarily the result of the decision by Alkermes and Genentech to discontinue commercialization of Nutropin Depot. ... $4.95 - Business Wire - ECNext Press Release: Examine the Changing Dynamics Prevelant in the US … - Sep 16, 2008 Article: US FDA: FDA approves Nutropin Depot, first lo long-acting dosage ... ... Nutropin Depot is a long-acting form of Genentech's human growth hormone ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: FVRL, GNVC, HYDG, OESX, OSCI, PHHM Have Also … - Jun 20, 2008 In the Phase III clinical trial, Nutropin Depot was ... month. The Phase III clinical trial was designed to test ... at 27 centers in the United States from ... Pay-Per-View - M2 Presswire - HighBeam Research A biogeneric company leads the field of next generation human growth ... - Oct 24, 2005 After Genentech had to terminate commercialisation of its Nutropin Depot preparation, the field now is lead by Korea-based LG Life Science and its European ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Genentech Stretches Nutropin Markets With New Approvals - Jul 8, 2005 Previously, a long-acting version also was on the market, Nutropin Depot, though a year ago Genentech and partner Alkermes Inc., of Cambridge, Mass., ... BioWorld Online - BioWorld Online Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Apr 15, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Federal Register 2007 - 72 FR 62858 Lederle Laboratories et al.; … - Nov 7, 2007 NDA 21-075 Nutropin Depot (somatropin Genentech Inc., 1 DNA Way recombinant) MS#242, South San Francisco, CA 94080-4990 ... Pay-Per-View - Federal Register 2007 - Loislaw Alkermes Reports Third Quarter Fiscal 2005 Financial Results. - Feb 3, 2005 ...consisting of approximately $2.7 million for Risperdal Consta and $1.4 million for Nutropin Depot(R). The increase in cost of goods manufactured for the ... Free with registration - Business Wire - AccessMyLibrary.com Merger and Acquisition Scenario - May 13, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Celltrion Bringing 50,000 Liters of Cell Culture to South Korea in... - Mar 7, 2005 As senior vice president of product operations at Genentech for over 20 years, Mr. Panek oversaw the production of Nutropin Depot, Protropin, TNKase, ... ICIS Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 11, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Press Release: A Biogeneric Company Leads the Field of Next … - Oct 24, 2005 After Genentech had to terminate commercialization of its Nutropin Depot preparation, the field now is lead by Korea-based LG Life Science and its European ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Aug 19, 2006 These products are Rituxan anti-CD20 antibody, Herceptin anti-HER2 antibody, Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth ... $250.00 - Revere Reports - Revere Press Release: Merck Serono Announces One-Month Results of … - Sep 23, 2008 Article: FDA Approves Nutropin Depot, First Long-Acting Dosage Form of ... Business Wire; December 23, 1999 ; 700+ words ... ... dosage form of recombinant ... Pay-Per-View - PR Newswire Europe - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |